Merck KGaA Closes $3.9B Deal to Acquire SpringWorks

April 28, 2025, 7:20 am more...

In a major strategic move for its healthcare portfolio, Merck KGaA has locked in a $3.9 billion acquisition of SpringWorks Therapeutics. The deal is aimed at bolstering its cancer treatment capabilities and accelerating future innovation, marking a significant industry shake-up.

pulse2.com / Merck KGaA Buying SpringWorks In $3.9 Billion Deal

techinasia.com / German healthcare firm Merck KGaA to buy SpringWorks for $3.9b

permalink / 2 stories from 2 sources in 5 hours ago #biotech #biotechnology #acquisitions #healthcare #pharmaceuticals +

Craif Secures $22M in Funding for Early Cancer Detection Startup

April 28, 2025, 12:20 am more...

Japanese healthtech startup Craif, spun off from Nagoya University, has secured $22M in its latest series C round—bringing its total funding to $57 million. The investment is set to bolster its microRNA-based early cancer detection technology amid booming global healthcare innovation.

Bluesky: @techcrunch.com

techinasia.com / Japanese healthtech startup Craif nets $22m series C

techcrunch.com / Early cancer detection startup Craif raises $22M

permalink / 3 stories from 3 sources in 12 hours ago #startups #biotech #digitalhealth #biotechnology #investments +